Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.120 | 12 | 55996852 | upstream gene variant | A/G | snv | 0.24 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.810 | 1.000 | 2 | 2012 | 2016 | |||||||
|
0.882 | 0.160 | 12 | 55991020 | non coding transcript exon variant | G/A | snv | 0.40 |
|
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.710 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.882 | 0.200 | 12 | 55995509 | 3 prime UTR variant | T/C | snv | 0.41 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 2 | 2019 | 2019 | |||||||
|
1.000 | 0.040 | 12 | 55974294 | intron variant | G/A | snv | 0.36 |
|
Digestive System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.882 | 0.160 | 12 | 55991020 | non coding transcript exon variant | G/A | snv | 0.40 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.882 | 0.160 | 12 | 55991020 | non coding transcript exon variant | G/A | snv | 0.40 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.882 | 0.160 | 12 | 55991020 | non coding transcript exon variant | G/A | snv | 0.40 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.882 | 0.160 | 12 | 55991020 | non coding transcript exon variant | G/A | snv | 0.40 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.882 | 0.200 | 12 | 55995509 | 3 prime UTR variant | T/C | snv | 0.41 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.925 | 0.120 | 12 | 55996580 | 3 prime UTR variant | C/G;T | snv |
|
Endocrine System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.925 | 0.120 | 12 | 55996580 | 3 prime UTR variant | C/G;T | snv |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||
|
0.882 | 12 | 55975722 | intron variant | A/G;T | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.882 | 12 | 55975722 | intron variant | A/G;T | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.882 | 12 | 55975722 | intron variant | A/G;T | snv |
|
Immune System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
0.882 | 12 | 55975722 | intron variant | A/G;T | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
12 | 55981353 | intron variant | C/G | snv | 0.24 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
1.000 | 0.120 | 12 | 55972376 | 3 prime UTR variant | G/C | snv | 0.15 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.120 | 12 | 55995838 | 3 prime UTR variant | G/A | snv | 4.0E-02 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.120 | 12 | 55992292 | 3 prime UTR variant | A/G | snv | 0.16 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.882 | 0.200 | 12 | 55995509 | 3 prime UTR variant | T/C | snv | 0.41 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.925 | 0.120 | 12 | 55996580 | 3 prime UTR variant | C/G;T | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 |